208 related articles for article (PubMed ID: 28895415)
1. Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
Liang Z; Zhang Q; Wang C; Shi F; Cao H; Yu Y; Zhang M; Liu X
Neoplasma; 2017; 64(6):901-908. PubMed ID: 28895415
[TBL] [Abstract][Full Text] [Related]
2. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade.
Lokeshwar VB; Obek C; Pham HT; Wei D; Young MJ; Duncan RC; Soloway MS; Block NL
J Urol; 2000 Jan; 163(1):348-56. PubMed ID: 10604388
[TBL] [Abstract][Full Text] [Related]
3. Elevated tissue expression of hyaluronic acid and hyaluronidase validates the HA-HAase urine test for bladder cancer.
Hautmann SH; Lokeshwar VB; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Soloway MS
J Urol; 2001 Jun; 165(6 Pt 1):2068-74. PubMed ID: 11371930
[TBL] [Abstract][Full Text] [Related]
4. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers].
Hautmann SH; Schroeder GL; Civantos F; Duncan RC; Gnann R; Friedrich MG; Hellstern A; Huland H; Soloway MS; Lokeshwar VB
Urologe A; 2001 Mar; 40(2):121-6. PubMed ID: 11315586
[TBL] [Abstract][Full Text] [Related]
5. Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid-hyaluronidase and BTA-Stat tests.
Lokeshwar VB; Schroeder GL; Selzer MG; Hautmann SH; Posey JT; Duncan RC; Watson R; Rose L; Markowitz S; Soloway MS
Cancer; 2002 Jul; 95(1):61-72. PubMed ID: 12115318
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of urinary survivin as a biomarker for bladder cancer: a systematic review and meta-analysis of published studies.
Liang Z; Xin R; Yu Y; Wang R; Wang C; Liu X
World J Urol; 2018 Sep; 36(9):1373-1381. PubMed ID: 29610963
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity and specificity of urinary hyaluronic acid and hyaluronidase in detection of bladder transitional cell carcinoma.
Jamshidian H; Hashemi M; Nowroozi MR; Ayati M; Bonyadi M; Najjaran Tousi V
Urol J; 2014 Mar; 11(1):1232-7. PubMed ID: 24595930
[TBL] [Abstract][Full Text] [Related]
8. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
[TBL] [Abstract][Full Text] [Related]
9. One-step facile synthesis of hyaluronic acid functionalized fluorescent gold nanoprobes sensitive to hyaluronidase in urine specimen from bladder cancer patients.
Cheng D; Han W; Yang K; Song Y; Jiang M; Song E
Talanta; 2014 Dec; 130():408-14. PubMed ID: 25159428
[TBL] [Abstract][Full Text] [Related]
10. HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade.
Lokeshwar VB; Block NL
Urol Clin North Am; 2000 Feb; 27(1):53-61. PubMed ID: 10696245
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors.
Franzmann EJ; Schroeder GL; Goodwin WJ; Weed DT; Fisher P; Lokeshwar VB
Int J Cancer; 2003 Sep; 106(3):438-45. PubMed ID: 12845686
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.
Skarmoutsos I; Skarmoutsos A; Katafigiotis I; Tataki E; Giagini A; Adamakis I; Alamanis C; Duvdevani M; Sitaras N; Constantinides C
Med Oncol; 2018 May; 35(7):97. PubMed ID: 29802604
[TBL] [Abstract][Full Text] [Related]
13. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis.
Kramer MW; Escudero DO; Lokeshwar SD; Golshani R; Ekwenna OO; Acosta K; Merseburger AS; Soloway M; Lokeshwar VB
Cancer; 2011 Mar; 117(6):1197-209. PubMed ID: 20960509
[TBL] [Abstract][Full Text] [Related]
14. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells.
Lokeshwar VB; Soloway MS; Block NL
Cancer Lett; 1998 Sep; 131(1):21-7. PubMed ID: 9839616
[TBL] [Abstract][Full Text] [Related]
15. A side by side comparison of cytology and biomarkers for bladder cancer detection.
Schroeder GL; Lorenzo-Gomez MF; Hautmann SH; Friedrich MG; Ekici S; Huland H; Lokeshwar V
J Urol; 2004 Sep; 172(3):1123-6. PubMed ID: 15311054
[TBL] [Abstract][Full Text] [Related]
16. Direct detection of hyaluronidase in urine using cationic gold nanoparticles: a potential diagnostic test for bladder cancer.
Nossier AI; Eissa S; Ismail MF; Hamdy MA; Azzazy HM
Biosens Bioelectron; 2014 Apr; 54():7-14. PubMed ID: 24240162
[TBL] [Abstract][Full Text] [Related]
17. Reaction-complexation coupling between an enzyme and its polyelectrolytic substrate: determination of the dissociation constant of the hyaluronidase-hyaluronan complex from the hyaluronidase substrate-dependence.
Lenormand H; Amar-Bacoup F; Vincent JC
Biophys Chem; 2013; 175-176():63-70. PubMed ID: 23523464
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma.
Liang Z; Liu X; Zhang Q; Wang C; Zhao Y
Dig Liver Dis; 2016 Oct; 48(10):1227-32. PubMed ID: 27476468
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
[TBL] [Abstract][Full Text] [Related]
20. How hyaluronan-protein complexes modulate the hyaluronidase activity: the model.
Vincent JC; Lenormand H
Biophys Chem; 2009 Dec; 145(2-3):126-34. PubMed ID: 19836126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]